Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism.
Parathyroid hormone (PTH) levels of patients with chronic renal failure (CRF) were measured by three different radioimmunoassays (RIA); RIA for mid-region PTH by antibody CH9 (i-PTH) (1), RIA for intact fragments of PTH (intact PTH) and RIA for C-terminal fragments of PTH (PTH-C). PTH levels were higher in CRF patients undergoing hemodialysis therapy (hemodialysis patients) by all three methods. However, PTH levels measured only by i-PTH assay and intact PTH assay were significantly higher in patients with CRF who were not on dialysis (non-dialyzed CRF patients). PTH levels were above normal when creatinine clearance was below 45 ml/min in the intact PTH assay and 66 ml/min in the i-PTH assay. I-PTH levels were well correlated with the severity of osteitis fibrosa evaluated by the degree of periosteal resorption in the digits of hemodialysis patients. Since special handling of the sample is required for the intact PTH assay, i-PTH assay is the most suitable method for diagnosing secondary hyperparathyroidism in patients with CRF.
Togashi
K
K
Kitasato Biochemical Laboratories, Kitasato University School of Medicine, Japan.
Takahashi
N
N
Ando
K
K
Tsukamoto
Y
Y
Marumo
F
F
D001851:Bone Diseases, Metabolic / Q000209:etiology / Q000473:pathology; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood* / Q000209:etiology; D007668:Kidney / Q000503:physiopathology; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood*; D010446:Peptide Fragments; D010758:Phosphorus / Q000097:blood; D011863:Radioimmunoassay / Q000379:methods*; D014511:Uremia / Q000150:complications* / Q000503:physiopathology
D010281:Parathyroid Hormone; D010446:Peptide Fragments; D010758:Phosphorus; D002118:Calcium